Arrowhead Pharmaceuticals' PIPE Round

Arrowhead Pharmaceuticals raised a round of funding on October 04, 2018. Investors include Johnson & Johnson Innovation – JJDC.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhe…

Articles about Arrowhead Pharmaceuticals' PIPE Round: